Novavax’s COVID-flu combo and standalone flu shots improve immunity in late-stage study

(Reuters) -Novavax’s experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)